Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03839992 · ClinicalTrials.gov registry record

Detection of Unsuspected Small Airways Obstruction in Cystic Fibrosis

A clinical trial of Cystic Fibrosis in Children, sponsored by Gelb, Arthur F., M.D..

Recruiting
Registry status
100
Enrollment target
2
Study locations

NCT03839992: Recruiting study of Cystic Fibrosis in Children, sponsored by Gelb, Arthur F., M.D..

NCT03839992 is a study of Cystic Fibrosis in Children that is actively recruiting participants, run by Gelb, Arthur F., M.D.. The registered enrollment target is 100 participants, above the 73-participant average among 6 other Cystic Fibrosis in Children trials with a reported enrollment target (37% higher). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03839992, a study of Cystic Fibrosis in Children, is actively recruiting participants, sponsored by Gelb, Arthur F., M.D..

RECRUITING
Registry status
100 participants
Enrollment target
2
Study locations

Study Summary

Goal is to physiologically detect unsuspected small airways obstruction in children and adults with treated heterozygous and homozygous cystic fibrosis. Unsuspected refers to normal routine pre bronchodilator spirometry including normal FEV1(L), FVC (L). and FEV1/FVC%. This is a retrospective study.

Primary Outcome

Retrospective analysis of pre bronchodilator spirometry, and lung CT study to detect abnormal FEF75% in the presence of normal spirometry and FEF25-75. Detect isolated abnormal pre bronchodilator spirometry at 75%FVC

Interventions

  • DIAGNOSTIC_TEST spirometry

Study Locations (2)

California

  • Arthur F Gelb MD - Lakewood
  • Miller Children's Hospital and Long Beach Medical Center - Long Beach

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2018-04-25
Est. Completion 2027-11-25
Gelb, Arthur F., M.D.

7 total trials

What NCT03839992 shows while recruiting

NCT03839992 is an observational study that tracks outcomes without assigning an intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, above the 73-participant average among 6 other Cystic Fibrosis in Children trials with a reported enrollment target (37% higher).

The record links to 1 condition, with Cystic Fibrosis in Children appearing as the primary indexed condition, and to 1 intervention - of which spirometry is the first listed.

NCT03839992 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT03839992 about?

NCT03839992 is a clinical study titled "Detection of Unsuspected Small Airways Obstruction in Cystic Fibrosis". Goal is to physiologically detect unsuspected small airways obstruction in children and adults with treated heterozygous and homozygous cystic fibrosis. Unsuspected refers to normal routine pre bronchodilator spirometry including normal FEV1(L), FVC (L). and FEV1/FVC%. This is a retrospective study.

What is the current status of trial NCT03839992?

This trial is currently recruiting. The enrollment target is 100 participants. The study started on 2018-04-25. Estimated completion is 2027-11-25.

What conditions does trial NCT03839992 study?

This clinical trial studies the following conditions: Cystic Fibrosis in Children.

What interventions are being tested in trial NCT03839992?

The interventions under investigation include: spirometry (DIAGNOSTIC_TEST).

Who is sponsoring clinical trial NCT03839992?

This trial is sponsored by Gelb, Arthur F., M.D., which has 7 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03839992 being conducted?

This trial has 2 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cystic Fibrosis in Children

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01048281 · 100 participants

    Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma

  • NCT01161199 · 100 participants

    The Use of Leukapheresis to Support HIV Pathogenesis Studies

  • NCT01327690 · 100 participants · Early Phase 1

    Mental Health in Veterans and Families After Group Therapies

  • NCT01730781 · 100 participants

    Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03839992, the US trial registry maintained by the National Library of Medicine. NCT03839992 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.